- Home
- XXII vs VERO Comparison
XXII vs VERO Comparison
Compare XXII & VERO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- XXII
- VERO
- Stock Information
- Founded
- XXII 1998
- VERO N/A
- Country
- XXII United States
- VERO Canada
- Employees
- XXII N/A
- VERO N/A
- Industry
- XXII Medicinal Chemicals and Botanical Products
- VERO Medical/Dental Instruments
- Sector
- XXII Health Care
- VERO Health Care
- Exchange
- XXII Nasdaq
- VERO Nasdaq
- Market Cap
- XXII 2.1M
- VERO 2.2M
- IPO Year
- XXII N/A
- VERO N/A
- Fundamental
- Price
- XXII $1.08
- VERO $2.20
- Analyst Decision
- XXII
- VERO
- Analyst Count
- XXII 0
- VERO 0
- Target Price
- XXII N/A
- VERO N/A
- AVG Volume (30 Days)
- XXII 603.9K
- VERO 92.7K
- Earning Date
- XXII 05-13-2025
- VERO 05-15-2025
- Dividend Yield
- XXII N/A
- VERO N/A
- EPS Growth
- XXII N/A
- VERO N/A
- EPS
- XXII N/A
- VERO N/A
- Revenue
- XXII $23,869,000.00
- VERO $60,997,000.00
- Revenue This Year
- XXII $19.23
- VERO N/A
- Revenue Next Year
- XXII $81.05
- VERO $7.55
- P/E Ratio
- XXII N/A
- VERO N/A
- Revenue Growth
- XXII N/A
- VERO N/A
- 52 Week Low
- XXII $0.70
- VERO $2.16
- 52 Week High
- XXII $226.80
- VERO $17.49
- Technical
- Relative Strength Index (RSI)
- XXII 47.15
- VERO 42.60
- Support Level
- XXII $1.06
- VERO $2.34
- Resistance Level
- XXII $1.26
- VERO $2.56
- Average True Range (ATR)
- XXII 0.17
- VERO 0.15
- MACD
- XXII 0.04
- VERO -0.00
- Stochastic Oscillator
- XXII 49.25
- VERO 19.57
About XXII 22nd Century Group Inc.
22nd Century Group Inc is a United States-based biotechnology company focused on utilizing alkaloid plant technologies to improve health and wellness with reduced nicotine tobacco, and hemp/cannabis. It has one operating segment; The tobacco segment is engaged in commercializing its proprietary VLNC tobacco plants and cigarette products, which contain nicotine than conventional tobacco and cigarettes, and research cigarettes sold under the brand name SPECTRUM. It derives a majority of its revenue from the tobacco segment.
About VERO Venus Concept Inc.
Venus Concept Inc is a medical technology company. It develops, commercializes, and delivers minimally invasive and non-invasive medical aesthetic and hair restoration technologies and related services. The company's products include NeoGraft, Venus Viva, Venus Legacy, Venus Versa, Venus Velocity, Venus Bliss, ARTAS systems, and others. The company provides medical devices and treatments for hair, body, and skin-related problems. It generates a majority of its revenue from the United States.